Propyl Thiouracil Market - Forecast(2022 - 2027)
Propyl Thiouracil Market Overview Propyl Thiouracil Market size is estimated to reach $3,000 million by 2026, growing at a CAGR of 10% over 2021-2026. Propylthiouracil are also called propranolol and is considered as an oral medication for the treatment of hyperthyroidism and also treat people with Graves ’ disease which acts by hampering the thyroid gland from producing excess thyroid hormone. Propylthiouracil is a medication that binds to thyroid peroxidase inhibitor for the conversion of iodide to iodine. Propylthiouracil is administered orally whose initial doses for adults is 300 mg daily and for pediatric patients doses is 50mg. Thiamazole are also called methimazole that reverses hyperthyroidism more quickly than propylthiouracil. Carbimazole are preferred antithyroid medicines than propylthiouracil owing to rising risk of hepatotoxicity with propylthiouracil. Growing prevalence of thyroid gland disorders and rising advanced infrastructure are the major factor driving the grow